Cefozopran Hydrochloride (CAS 113981-44-5) Suppliers and Product Information

Cefozopran hydrochloride is a semi-synthetic parenteral fourth-generation cephalosporin with broad-spectrum antibacterial activity. It is effective against most Gram-negative and Gram-positive bacteria in vitro, including methicillin-susceptible staphylococci, enterococci, viridans group streptococci, Haemophilus influenzae, and Pseudomonas aeruginosa.

Frequently Asked Questions

Q: What is the main use of Cefozopran hydrochloride?

A: Cefozopran hydrochloride is primarily used as an antibiotic to treat various bacterial infections. It is effective against a wide range of Gram-positive and Gram-negative bacteria, including some that are resistant to other cephalosporins.

Q: How is Cefozopran hydrochloride administered?

A: Cefozopran hydrochloride is typically administered parenterally (by injection or infusion). In animal studies, it has been administered subcutaneously at doses ranging from 5-80 mg/kg twice daily for 5-7 days.

Q: What are some specific infections that Cefozopran hydrochloride can treat?

A: Cefozopran hydrochloride is suitable for treating infections caused by sensitive bacteria, including septicemia, trauma infections, respiratory system infections, urinary system infections, abdominal cavity and pelvic purulent inflammations, and ophthalmology and ENT inflammations.